The system allows for precise placement of approved biologic material into an implanted cage. This method has shown to dramatically improve endplate-to-endplate biologic engagement.
The newly-patented system works with Pinnacle's InFill Direct Lateral System and includes a retractor system, extensive disc and endplate preparation options and specialized instruments to address challenging fusion levels.
More Articles on Devices:
Orthopedic & Spine Industry Company to Know: PDP Holdings
SI-BONE Tops 4k Patients Treated With iFuse
RTI Biologics Launches Biologic Putty Implant for Orthopedics, Spine
a
Pinnacle Spine Group Receive Graft Delivery System Patent
Written by Heather Linder | November 15, 2012
Dallas-based Pinnacle Spine Group has received a U.S. Patent for its InFill Graft Delivery System, according to Virtual-Strategy.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.




